XB3 Trademark

Trademark Overview

On Monday, January 29, 2018, a trademark application was filed for XB3 with the United States Patent and Trademark Office. The USPTO has given the XB3 trademark a serial number of 87775067. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 3, 2022. This trademark is owned by Bioasis Technologies, Inc.. The XB3 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, synthetic peptides and synthetic peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases

Drug discovery services, research, development, engineering and testing of pharmaceuticals and substances, namely, peptides and peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases
xb3

General Information

Serial Number87775067
Word MarkXB3
Filing DateMonday, January 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 3, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical products, namely, synthetic peptides and synthetic peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases
Goods and ServicesDrug discovery services, research, development, engineering and testing of pharmaceuticals and substances, namely, peptides and peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 8, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioasis Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437
Party NameBioasis Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGuilford, CT 06437

Trademark Events

Event DateEvent Description
Monday, January 3, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 3, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 11, 2021EXTENSION 4 GRANTED
Tuesday, May 11, 2021EXTENSION 4 FILED
Tuesday, May 11, 2021TEAS EXTENSION RECEIVED
Tuesday, November 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 6, 2020EXTENSION 3 GRANTED
Friday, November 6, 2020EXTENSION 3 FILED
Friday, November 6, 2020TEAS EXTENSION RECEIVED
Friday, November 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 29, 2020EXTENSION 2 GRANTED
Wednesday, April 29, 2020EXTENSION 2 FILED
Wednesday, April 29, 2020TEAS EXTENSION RECEIVED
Saturday, November 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2019EXTENSION 1 GRANTED
Thursday, November 14, 2019EXTENSION 1 FILED
Thursday, November 14, 2019TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Monday, March 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 28, 2019ASSIGNED TO LIE
Wednesday, January 23, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, November 24, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, November 24, 2018FINAL REFUSAL E-MAILED
Saturday, November 24, 2018FINAL REFUSAL WRITTEN
Saturday, November 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 9, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 9, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 18, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 18, 2018NON-FINAL ACTION E-MAILED
Friday, May 18, 2018NON-FINAL ACTION WRITTEN
Thursday, May 10, 2018ASSIGNED TO EXAMINER
Thursday, February 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 1, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

disorders diseases inflammatory pain neurological conditions infectious cancers allergies metabolic